Kimberly-Clark (NYSE:KMB) Given New $151.00 Price Target at UBS Group

Kimberly-Clark (NYSE:KMB) had its price objective dropped by stock analysts at UBS Group from $153.00 to $151.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s price objective would indicate a potential upside of 10.29% from the stock’s previous close.

Several other equities analysts have also issued reports on the stock. Wells Fargo & Company cut their price objective on shares of Kimberly-Clark from $138.00 to $134.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Kimberly-Clark from $146.00 to $147.00 and gave the company a “hold” rating in a research note on Tuesday, October 8th. TD Cowen started coverage on shares of Kimberly-Clark in a research report on Tuesday, July 23rd. They set a “buy” rating and a $161.00 target price for the company. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $165.00 price objective on shares of Kimberly-Clark in a report on Wednesday, July 24th. Finally, StockNews.com cut shares of Kimberly-Clark from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 30th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, Kimberly-Clark currently has an average rating of “Hold” and a consensus target price of $150.07.

Kimberly-Clark Trading Down 0.6 %

Shares of NYSE:KMB traded down $0.84 during trading on Wednesday, reaching $136.91. The company’s stock had a trading volume of 759,169 shares, compared to its average volume of 2,112,634. The company has a current ratio of 0.85, a quick ratio of 0.58 and a debt-to-equity ratio of 5.59. The stock has a market capitalization of $46.10 billion, a PE ratio of 25.17, a price-to-earnings-growth ratio of 2.98 and a beta of 0.39. Kimberly-Clark has a 12 month low of $116.63 and a 12 month high of $149.30. The firm’s 50 day simple moving average is $143.26 and its two-hundred day simple moving average is $138.67.

Kimberly-Clark (NYSE:KMB) last announced its quarterly earnings data on Tuesday, October 22nd. The company reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.14. The business had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $5.06 billion. Kimberly-Clark had a net margin of 11.28% and a return on equity of 223.55%. The firm’s quarterly revenue was down 3.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.74 earnings per share. On average, research analysts predict that Kimberly-Clark will post 7.25 EPS for the current fiscal year.

Insider Transactions at Kimberly-Clark

In other news, insider Gonzalo Uribe sold 1,780 shares of the firm’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the completion of the sale, the insider now owns 7,377 shares in the company, valued at approximately $1,038,976.68. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, insider Gonzalo Uribe sold 1,780 shares of the firm’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the completion of the sale, the insider now owns 7,377 shares in the company, valued at $1,038,976.68. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jeffrey P. Melucci sold 37,699 shares of the firm’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the completion of the sale, the insider now owns 19,935 shares of the company’s stock, valued at $2,819,207.70. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.62% of the company’s stock.

Hedge Funds Weigh In On Kimberly-Clark

Several hedge funds have recently added to or reduced their stakes in KMB. William B. Walkup & Associates Inc. purchased a new position in Kimberly-Clark during the 2nd quarter valued at about $26,000. Crewe Advisors LLC purchased a new position in Kimberly-Clark during the 1st quarter valued at about $27,000. New Millennium Group LLC purchased a new stake in shares of Kimberly-Clark during the second quarter worth about $28,000. Strategic Financial Concepts LLC purchased a new stake in shares of Kimberly-Clark during the second quarter worth about $32,000. Finally, DiNuzzo Private Wealth Inc. grew its holdings in shares of Kimberly-Clark by 808.0% during the third quarter. DiNuzzo Private Wealth Inc. now owns 227 shares of the company’s stock worth $32,000 after buying an additional 202 shares in the last quarter. 76.29% of the stock is currently owned by hedge funds and other institutional investors.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.